广州市耐多药肺结核患者自付医疗费用及影响因素分析OA北大核心CSTPCD
Analysis of self-paid medical expenses and influencing factors for multidrug-resistant tuberculosis patients in Guangzhou City
目的:调查广州市耐多药肺结核患者自付医疗费用和影响因素,为优化耐多药肺结核患者医疗报销政策提供依据.方法:对2020年1月1日至2022年12月31日在广州市胸科医院耐多药专科诊室接受治疗的患者284例,采用自行设计的调查问卷通过面对面或电话进行耐多药肺结核相关因素调查.通过医院信息系统收集患者自付医疗费用(包括实验室检查费、抗结核药品费、非抗结核药品费、住院费等).采用描述性统计分析、卡方检验分析不同年龄、性别、家庭收入、职业及教育程度等情况下耐多药肺结核患者的自付医疗费用.采用逐步多重线性回归分析耐多药肺结核患者自付医疗费用的影响因素;检验水准α=0.05.结果:284例耐多药肺结核患者自付医疗费用中位数(四分位数)为99 927.25(40 136.45,202 526.91)元,前3位分别为抗结核药品费、实验室检查费和非抗结核药品费,中位数(四分位数)分别为46 676.27(5590.92,150 869.86)元、22 130.59(15 609.23,31417.06)元和12 751.68(7977.07,19 418.64)元;多因素分析模型中,耐多药肺结核患者自付医疗费用的保护因素是广州市户籍[OR(95%CI)=0.95(0.84~0.99)]、全程面视服药管理[OR(95%CI)=0.73(0.65~0.87)],危险因素是药物不良反应[OR(95%CI)=1.33(1.19~1.46)]、使用利奈唑胺[OR(95%CI)=2.23(1.92~2.59)]、住院治疗[OR(95%CI)=1.57(1.32~1.91)].结论:广州市耐多药肺结核患者自付医疗费用较高,应规范耐多药患者服药管理,减少药物不良反应,优化医疗报销政策.
Objective:To investigate the current situation and influencing factors of the direct self-paid medical expenses of multidrug-resistant tuberculosis(MDR-TB)patients in Guangzhou City,providing a basis for optimizing medical reimbursement policies for MDR-TB patients.Methods:A self-designed questionnaire was used to conduct face-to-face or telephone interviews on factors related to MDR-TB in 284 patients who completed treatment receive treatment in the MDR-TB clinic of Guangzhou Chest Hospital from January 1,2020 to December 31,2022.The direct self-paid medical expenses and information of examinations of patients(including laboratory examination fees,anti-tuberculosis drug fees,non tuberculosis drug fees,hospitalization fees,etc.)were collected through the hospital information system.Descriptive statistical analysis,Chi square test,and other methods were used to analyze direct self-paid medical expenses of MDR-TB patients with different age,gender,family income,occupation,and education levels.Stepwise multiple linear regression was conducted to analyze the influencing factors of direct self-paid medical expenses(α=0.05).Results:The median(quartile)direct self-paid medical expenses of 284 MDR-TB patients was 99 927.25(40 136.45,202 526.91)RMB yuan,the top three were anti-TB drug expenses,laboratory examination expenses,and non-anti-TB drug expenses,with median(quartile)of 46 676.27(5590.92,150 869.86)RMB yuan,22 130.59(15 609.23,31 417.06)RMB yuan,and 12 751.68(7977.07,19 418.64)RMB yuan,respectively.In the multi-factorial analysis model,the protective factors for self-paid medical expenses of MDR-TB patients were Guangzhou City household registration(OR(95%CI)=0.95(0.84-0.99)),and full face-to-face medication management(OR(95%CI)=0.73(0.65-0.87)),and the risk factors for self-paid medical expenses of MDR-TB patients were having adverse drug reactions(OR(95%CI)=1.33(1.19-1.46)),using linezolid(OR(95%CI)=2.23(1.92-2.59)),and having hospitalization(OR(95%CI)=1.57(1.32-1.91)).Conclusion:The self-paid medical expenses of multidrug-resistant tuberculosis patients in Guangzhou are high,and the management of multidrug-resistant patients'medication should be standardized to reduce adverse drug reactions and optimize medical reimbursement policies.
李雪秋;邝浩斌;王挺;闵飞;陶岚;曹细惠;李祥;刘国标
广州市胸科医院结核病防治所一分所/广州市结核病研究重点实验室/呼吸疾病全国重点实验室,广州 510095广州市胸科医院结核内科/广州市结核病研究重点实验室/呼吸疾病全国重点实验室,广州 510095广州市胸科医院结控办/广州市结核病研究重点实验室/呼吸疾病全国重点实验室,广州 510095广州市胸科医院综合门诊/广州市结核病研究重点实验室/呼吸疾病全国重点实验室,广州 510095广州市胸科医院科教科/广州市结核病研究重点实验室/呼吸疾病全国重点实验室,广州 510095广州市胸科医院药剂科/广州市结核病研究重点实验室/呼吸疾病全国重点实验室,广州 510095
预防医学
分枝杆菌,结核结核,抗多种药物性费用,医疗因素分析,统计学
Mycobacterium tuberculosisTuberculosis,resistant to multiple drugsExpenses,medicalFactor analysis,statistics
《中国防痨杂志》 2024 (004)
411-417 / 7
广州市科技计划项目(2023A03J0539);国家重点研发计划"病原学与防疫技术体系研究"重点专项(2022YFC2304800);广州市卫生健康科技项目(20241A011048) Science and Technology Program of Guangzhou(2023A03J0539);National Key Research and Development Program of China(2022YFC2304800);Guangzhou Municipal Health Science and Technology Project(20241A011048)
评论